NewYork-Presbyterian Ventures

NewYork-Presbyterian Ventures is the venture arm of NewYork-Presbyterian Hospital, focused on novel digital health technologies that improve operational efficiency within dense urban hospitals. As a corporate VC, the New York-based team aligns financial returns with strategic value, particularly companies that can be piloted or deployed inside a major academic medical center serving a complex urban patient population. The fund’s identified areas of interest are digital health and Health IT and healthcare software. AI focus is not formally indicated, though AI-enabled clinical and operational tools that demonstrably improve hospital efficiency align with the stated thesis.

Investments are made at seed and Series A stages with check sizes between $1M and $5M. Activity is U.S.-focused, with a particular emphasis on companies whose products solve problems characteristic of large, multi-site urban hospitals. The team typically co-invests alongside traditional venture firms and peer health system funds, contributing clinical input and pilot opportunities rather than leading priced rounds.

For founders, a productive approach starts with a precise operational or clinical workflow problem inside an academic medical center and a credible plan to validate impact through a pilot. AI capabilities should be presented with attention to data governance, integration with EHRs, and safety. Limited public information is available about granular intake preferences, so introductions through NewYork-Presbyterian clinicians, innovation leaders, and other large health system VCs remain the most effective entry points.